review·Nature Reviews Clinical Oncology·Mar 6, 2025Closed access

Enhancing immunotherapy with tumour-responsive nanomaterials

SWStephen W. LindermanLDLouis DeRidderLSLucía SanjurjoMBMichael B. FooteMJMarı́a José Alonso

Beth Israel Deaconess Medical Center · Massachusetts Institute of Technology · +10 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

95
total citations
FWCI
49.68
Percentile
100%
References
231
Citations per year

Authors

8
  • SW
    Stephen W. Linderman

    Beth Israel Deaconess Medical Center, Massachusetts Institute of Technology

  • LD
    Louis DeRidder

    Massachusetts Institute of Technology

  • LS
    Lucía Sanjurjo

    Universidade de Santiago de Compostela, Center for Research in Molecular Medicine and Chronic Diseases, Instituto de Investigación Sanitaria de Santiago

  • MB
    Michael B. Foote

    Memorial Sloan Kettering Cancer Center

  • MJ
    Marı́a José Alonso

    Madrid Institute for Advanced Studies, Universidade de Santiago de Compostela, IMDEA Nanoscience, Center for Research in Molecular Medicine and Chronic Diseases

Topics & keywords

Topics
  • Primary topicNanoplatforms for cancer theranostics100%
  • Nanoparticle-Based Drug Delivery100%
  • Immunotherapy and Immune Responses100%
Keywords
  • Medicine
  • Immunotherapy
  • Cancer immunotherapy
  • Cancer research
  • Oncology
  • Internal medicine
  • Cancer
No related works found for this paper.